Axa S.A. Spectrum Pharmaceuticals Inc Transaction History

Axa S.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$0.63 - $1.59 $16,443 - $41,499	-26,100 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$1.27 - $2.42 $472,059 - $899,514	-371,700 Reduced 93.44%	26,100 $33,000
Q3 2021 Nov 15, 2021	BUY	$2.15 - $3.82 $266,600 - $473,680	124,000 Added 45.29%	397,800 $867,000
Q2 2021 Aug 13, 2021	SELL	$2.89 - $4.45 $19,074 - $29,370	-6,600 Reduced 2.35%	273,800 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$2.11 - $3.38 $58,869 - $94,302	27,900 Added 11.05%	280,400 $948,000
Q1 2020 May 15, 2020	BUY	$1.83 - $3.45 $462,075 - $871,125	252,500 New	252,500 $588,000

115K

Ticker SPPI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,164,000
Description
Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor ...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.